reports
Moody's Ratings says Cencora's planned acquisition of select retina as...
Announcement: Moody's Ratings says Cencora's planned acquisition of select retina assets from EyeSouth expands company's presence in retina MSO, ratings not impacted. Global Credit Research- 23 Mar 2026. New York, March 23, 2026-- Moody's Ratings says that Cencora Inc.' s planned acquisition of select retina assets from EyeSouth Partners will expand Cencora's scale and diversity in retina management services, a modestly credit positive development.
Moody's Ratings says Cencora's divestiture of MWI Animal Health will r...
Moody's Ratings (Moody's) says that Cencora Inc.'s (Baa1 stable) planned divestiture of Cencora's MWI animal health distribution business is credit negative because it will reduce Cencora's scale and diversity. However, should the divestiture receive regulatory approval, it would result in meaningfu...
Moody's Ratings assigns Baa1 rating to Cencora's new senior unsecured ...
Moody's Ratings (Moody's) assigned a Baa1 rating to Cencora, Inc.'s (Cencora) new senior unsecured notes offering. There are no changes to the company's existing Baa1 senior unsecured ratings and Prime-2 commercial paper rating. The outlook is stable. We expect net proceeds of the $3.0 billion sen...
Moody's Ratings says Cencora's acquisition of OneOncology is credit ne...
Moody's Ratings (Moody's) says that Cencora Inc.'s (Baa1 stable) acquisition of majority of the outstanding equity interest it does not already own in OneOncology for approximately $3.6 billion and retirement of $1.3 billion of OneOncology's debt, for a total of approximately $5 billion is credit ne...
Moody's Ratings upgrades Cencora's senior unsecured rating to Baa1, ou...
Moody's Ratings (Moody's) upgraded Cencora, Inc.'s (Cencora) senior unsecured ratings to Baa1 from Baa2. At the same time, we affirmed Cencora's Prime-2 short term commercial paper rating. Following these actions, the outlook was changed to stable from positive. The upgrade to Baa1 reflects Cencor...
Moody's Ratings assigns Baa2 rating to Cencora's new senior notes
Moody's Ratings (Moody's) assigned a Baa2 rating to Cencora, Inc.'s ("Cencora") new senior unsecured notes. There are no changes to the company's existing Baa2 senior unsecured rating and Prime-2 commercial paper rating. The outlook is positive. We expect that Cencora will use net proceeds from th...
Moody's Ratings announces completion of a periodic review of ratings o...
Moody's Ratings (Moody's) has completed a periodic review of the ratings of Cencora, Inc. and other ratings that are associated with this issuer. The review was conducted through a rating committee held on 25 February 2025 in which we reassessed the appropriateness of the ratings in the context of ...
Moody's Ratings assigns Baa2 rating to Cencora's new senior unsecured ...
Moody's Ratings (Moody's) assigned a Baa2 rating to Cencora, Inc.'s (Cencora) new senior unsecured notes offering. There are no changes to the company's existing Baa2 senior unsecured ratings and Prime-2 commercial paper rating. The outlook is positive. We expect net proceeds of the $1.8 billion s...
Moody's Ratings says Cencora's acquisition of Retina Consultants of A...
Moody's Ratings (Moody's) says that Cencora Inc.'s (Baa2 positive) acquisition of Retina Consultants of America ("RCA", not rated) for $4.6 billion is credit negative. We expect the transaction will result in a meaningful increase of Cencora's debt levels, slowing its deleveraging trajectory. Howeve...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.